About: http://data.cimple.eu/news-article/2251735d7c9eee2df1fed38beacb63e6d24e9fc528b5c72d462a57d1

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/2251735d7c9eee2df1fed38beacb63e6d24e9fc528b5c72d462a57d1 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Wall Street stocks rose again early Friday amid optimism about coronavirus therapeutics and as investors monitored stimulus talks in Washington in hopes of a breakthrough. About 15 minutes into trading, the Dow Jones Industrial Average was up 0.4 percent at 28,527.85. The broad-based S&P 500 advanced 0.5 percent to 3,465.51, while the tech-rich Nasdaq Composite Index jumped 0.7 percent to 11,505.13. Markets cheered a write-up in the New England Journal of Medicine that Gilead Sciences' remdesivir drug resulted in "consistent, clinically meaningful improvements" in coronavirus patients, the latest positive indicator about a leading treatment. Gilead rose 1.0 percent. That news follows announcements by Regeneron Pharmaceuticals and Eli Lilly earlier in the week on Covid-19 therapies that have boosted confidence in effectiveness of the treatments for the virus. Analysts also remained hopeful that Washington policymakers finally will reach a deal on stimulus spending following various pivots in recent days between the White House and congressional leaders. But there are still a number of challenges to a deal, including opposition to a larger stimulus package in the Republican-controlled Senate. jmb/hs
schema:headline	US stocks rise again on hopes for Covid-19 therapies
schema:mentions	Eli Lilly and Company S&P 500 Index Dow Jones Industrial Average USA Gymnastics New England Remdesivir University of Washington Ebola virus disease United States Senate White House Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Regeneron Pharmaceuticals Gilead Sciences NASDAQ Composite »more»
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-10-09 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	76 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software